Nearly 10,000 incidents of workplace violence were reported at New Jersey health care facilities in 2021. That’s a 14.6% increase over the past three years.

Saturday's announcement comes just days before regulators debate whether to offer Americans updated booster shots this fall.

The nation’s infants, toddlers and preschoolers are finally getting their chance at COVID-19 vaccination as the U.S. rolls out shots for tots this week.

People who catch COVID may feel as if they won't get it again, at least not for a long time. Their immune system should be primed to fight it off in the future. Right?

As a third pandemic school year draws to a close, new research offers the clearest accounting yet of the pandemic's academic toll.

U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.

U.S. regulators have authorized the first COVID-19 shots for infants and preschoolers. That paves the way for vaccinations for children under 5 to begin next week.

An advisory panel for the Food and Drug Administration gave a thumbs-up Wednesday to vaccines from Moderna and Pfizer for children under 5.

The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17.

On Wednesday, the FDA will ask an independent panel of vaccine experts to debate both Pfizer's and Moderna’s vaccine data before voting.

Kids under 5 may be able to get the COVID-19 vaccine at the end of June. Pediatricians in the region explain what you need to know.

The money could provide a crucial boost for the district at a very difficult time for city schools.

Since 2020, Pa. pharmacies have benefitted from emergency flexibilities, which allowed them to more easily vaccinate both adults and children. Those waivers are set to expire.

The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate to have an effective booster ready for fall of 2022, the company said.

It's a protein vaccine, a more conventional technology than the dominant Pfizer and Moderna shots, and the lesser-used Johnson & Johnson option.